Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth
Xuechao Jia(Zhengzhou University), Kangdong Liu(Zhengzhou University), Bingbing Lu(Zhengzhou University), Yanan Jiang(Institute of Plant Protection), Dengyun Zhao(Zhengzhou University), Wenna Nie(China-US (Henan) Hormel Cancer Institute), Chuntian Huang(Zhengzhou University), Limeng Huang(China-US (Henan) Hormel Cancer Institute), Zigang Dong(Zhengzhou University), Penglei Wang(Zhengzhou University), Kyle Vaughn Laster(China-US (Henan) Hormel Cancer Institute), Xiang Li(Zhengzhou University), Pan Li(Brigham and Women's Hospital), Honglin Li(Sichuan University), Xueli Tian(Zhengzhou University), Qiong Wu(Zhengzhou University)
Cited by 16
Related Papers
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
|Proceedings of the National Academy of Sciences|1994|388
Association analyses identify six new psoriasis susceptibility loci in the Chinese population
|Nature Genetics|2010|317
NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data
|Nucleic Acids Research|2020|187
Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK
|Carcinogenesis|2011|123
Epigallocatechin Gallate Suppresses Lung Cancer Cell Growth through Ras–GTPase-Activating Protein SH3 Domain-Binding Protein 1
|Cancer Prevention Research|2010|115